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THE NETWORK PROJECT ON MEDICINAL PLANTS AND 




1.1 The Scope and Structure of the Network 
 
The Kenyan Network for Medicinal Plants and Traditional Medicine is part of the 
IDRC-CDRI supported Regional Eastern African Network, the latter of which also 
includes participating stakeholder institutions from Uganda and Tanzania.  This network 
project sought to establish a programmatic and collaborative platform that provides  
opportunity for enhanced all stakeholder (traditional health care providers, indigenous 
communities, researchers, NGOs, governments, development partners, consumers and 
private entrepreneurs) sharing of experiences, research designs and methods, project 
implementation, monitoring and evaluation strategies and relevant information to 
promote biodiversity conservation, and sustainable, safe and effective utilization of 
medicinal plants and herbal products as well as the integration of traditional medicine 
into the national health care policy. 
 
The Regional Network is funded for an initial period of three years and its scope 
and project objectives are similar in each of the three countries with a national institution 
coordinating the national implementation and one regional theme.  The coordinating and 
implementing institution for the Kenyan component of the regional network is the 
National Museums of Kenya (NMK). 
 
Coordination of the Kenyan component for the Regional Network by NMK 
operates through a secretariat under the National Project Leader and two committees, 
namely, the Steering and Technical Advisory Committees.  The Steering Committee 
constituted of key stakeholder institutions provides the overall guidance and evaluation of 
the project activities while the Technical Advisory Committee made up of technical 
experts in conservation, research, policy, community development and information 
technology facilitates strategic and effective project implementation. 
 
The current lists of key stakeholder institutions in Kenya include: 
 
1. Traditional Health Practitioner Associations 
2. Department of Culture in the Ministry of Gender, Sports, Culture and Social 
Services. 
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3. Department of Standards and Regulatory Services (DSRS) of the Ministry of 
Health. 
4. Kenya Medical Research Institute (KEMRI) 
5. National Council for Population and Development (NCPD) in the Ministry of 
Planning and National Development. 
6. Kenya Industrial Research Development Institute (KIRDI). 
 
7. National Council of Science and Technology (NCST) in the Ministry of 
Education, Science and Technology. 
8. Kenya Agricultural Research Institute (KARI) in the Ministry of Agriculture. 
9. Department of Forests in the Ministry of Environmental and Natural Resources. 
10. Kenya Intellectual Property Institute (KIPI) in the Ministry of Trade and Industry. 
11. Kenya Forestry Research Institute (KEFRI). 
12. National Environment Management Authority (NEMA). 
13. University of Nairobi (UoN). 
14. Kenyatta University (KU). 
15. Maseno University. 
16. Kenya Working Group on Medicinal and Aromatic Plant Species (KWG-MAPS). 
17. Intermediate Technologies Development Group (ITDGEA). 
18. School of Alternative Medicine and Technology (SAMTECH). 
19. African Academy of Sciences (AAS). 
20. African Centre for Technology Studies (ACTS). 
21. International Centre for Insect Physiology and Ecology (ICIPE). 
22. International Plant Genetic Resource Institute (IPGRI). 
23. International Centre for Research in Agro-Forestry (ICRAF). 
 
It was anticipated that themes and activities within this network based on national 
priorities and regional needs would expand at the end of the initial phase and relevant 
support identified and consolidated for subsequent phases.  The Network on Medicinal 
Plants and Traditional Medicine has invited all interested national, international and 
private organizations including development partners to join in this initiative. 
 
1.2 General Objective 
 
To promote the conservation and sustainable, safe and effective use of medicinal plants 
and herbal products as well as the integration of traditional medicine in public health 
services through collaboration among all stakeholders. 
 
1.3 Specific Objectives 
 
a. Assess current research activities, policy and legal frameworks on medicinal 
plants and traditional medicine in Kenya, in order to identify gaps and determine 
national research priorities. 
b. Enhance research capacity and harmonization of research approaches and 
methodologies for sustainable management of medicinal plants and their uses in 
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c. Promote the development of collaborative projects on herbal remedies, 
conservation of medicinal plants and sustainable livelihoods in Kenya. 
d. Strengthen the capacity of Kenyan traditional health practitioner Associations 
and the collaboration between them and health workers, researchers and 
policy/decision makers in order to support integration of traditional medicine in 
the public health care. 
e. Contribute to the development and implementation of appropriate policies and 
legal frameworks pertaining to medicinal biodiversity conservation, traditional 
medicine access and benefit sharing at local, national, regional and international 
levels. 
f. Develop partnerships with mass media, the government of Kenya, national, 
regional and international organizations for dissemination and scaling-up of 
research results on medicinal plants. 
 
2.0 Terms Of Reference For The Consultancy 
 
The consultant shall: 
 
a. Evaluate the continued need, structure and scope of the project. 
b. Outline gaps in the current project and recommend priority future focal 
areas for network activities. 
c. Review and outline potential donor support (government, NGO, bilateral, 
multilateral, private sector and foundations) available to support projects 
in the current and proposed future focal activities in traditional medicine 
and medicinal plant conservations, research and sustainable use. 
d. Develop and recommend a resource expansion strategy for the network 
activities from 2005-2010 to ensure the implementation of the network 
activities and its sustainability. 
 
 
3.0 EVALUATION OF THE CONTINUED NEED, 
STRUCTURE AND SCOPE OF THE PROJECT 
 
3.1 THE SUSTAINED NEED FOR MEDICINAL PLANTS AND 
INDIGENOUS PHYTO-MEDICINES. 
 
(a) Accessibility, Healthcare and Nutritional needs 
 
  The demand for medicinal plants and the utilization of traditional 
medicine as a major source of primary health care in the developing world have 
maintained an unprecedented upward trend despite attempts by many such 
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countries to increase access and equity to conventional health services among 
their citizenry through improved infrastructure and facility development and 
concomitant increased volume of medical supplies.  Availability in the wild of 
many medicinal plants, affordability and acceptability of traditional medicine by 
indigenous communities in developing countries may partially account for this 
observation (ROK, 2003a). The other main plausible reasons that have instigated 
the continued use of herbal source materials as captured in the report by Kayne 
(2002) include the: 
 
 (i) Long periods of experience with traditional remedies by  
  indigenous communities. 
(ii) Observations that many isolated constituents are to be  
 found in modern drugs. 
(iii) Ready availability of a large pool of plant materials in the tropics 
and subtropics. 
(iv) Profit motive for pharmaceutical companies arising from increased 
customer demand. 
 
Traditional Medicine Practice in Kenya derives from two distinct sources 
(Lambert, 2004b).  In the first group is the Indigenous Traditional Medicine 
Practitioners (ITMP) whose knowledge-base is dependent on non-recorded verbal 
communication passed on from generation to generation. Indigenous traditional 
medicine practitioners include traditional herbalists, bonesetters, birth attendants, 
astrologers, seers, fortune-tellers and faith-healers.  Also included in this group 
are the practitioners and providers of all other types and variations of indigenous 
African primary health care whose object is the treatment of physical, 
psychological or psychiatric conditions.   
 
The second group comprises the Non-Indigenous Traditional Medicine 
Practitioner (NITMP) who has received training in other forms of non-
conventional medicine usually with some written record such as Ayurveda, 
Chinese Herbal Medicine, Unani Medicine, Reflexology, Reiki, Chiropractice, 
Acupuncture, Aromatherapy and Homeopathy.  Both groups exclude quacks and 
witch-doctors with the intent of causing harm and fear.  Kenya like the rest of 
tropical Africa has probably a longer history of traditional medicine use than other 
continents if we accept the origin of man being in Africa (Lambert, 2004a) 
 
  Recorded evidence indicates that medicinal plant resources contribute on 
the average about 50,000 species to the global biodiversity (Hamilton, 2002; 
Schipmann et al., 2002).  In the rest of tropical Africa outside South and North 
Africa, Bosch et al., (2002) reported that 63% of the recorded 6,377 plant species 
had medicinal value.  Furthermore, it was recently estimated that close to 3.5 
billion people of the world population of 6.3 billion, mainly in the developing 
world use traditional health care systems (Rogo, 2004).  It is instructive that 
indigenous methods of health care provision are globally popular, affordable, 
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culturally deep-rooted, respected and accepted by local communities since time 
immemorial (Artherton, 1994).  The use of traditional medicine (synonymous in 
the West with Complementary and Alternative Medicine, CAM) has likewise 
consistently gained immense popularity and acceptability in the USA and Europe 
over the last decade (Fisher and Ward, 1994; Kayne, 2002; Rogo, 2004). 
 
  The World Health Organization (WHO) estimated that 80% or more of 
populations in many developing countries in WHO Western Pacific Region where 
CAM have been integrated into national healthcare delivery systems obtained 
health care from traditional practitioners and birth attendants (Bannerman, 1983; 
Tsutani, 1993).  In other developing WHO Regions where CAM integration has 
not been implemented, there is inadequate documentation since only a minority of 
the population have regular access to reliable modern medical services leaving 
most of the population to regularly use traditional medicine (WHO, 1996a; 
Bodeker, 2001; Eriki, 2004).  In Kenya and the rest of the WHO African Region, 
between 60% and 80% of the population do not have ready access to modern 
medicine and rely almost wholly on traditional remedies as the primary healthcare 
resource (Maitai, 1996, Ngetich, 2004; Eriki, 2004).  Accessibility of traditional 
medicine and practitioners as a major source of primary health care in African 
countries was illustrated and strongly supported by the data summarized in Table 
1 below from Eriki (2004) and Marshal (1998). 
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Table 1: Traditional medicine and Practitioners as a major source of primary 
health care in African countries:  Ratio of practitioners to population. 
 
Country Traditional practitioner Medical doctor 
Zimbabwe 1: 600 1: 6,250 
Swaziland 1: 100 1: 10,000 
Ghana 1: 200 1: 20,000 
Uganda 1: 700 1: 25,000 
Tanzania 1: 400 1: 33,000 
Mozambique 1: 200 1: 50,000 
Kenya* 1: 378 1: 7142 
 
Source: Eriki P. (2004) WHO/AFRO Division of Health Systems and Services 
Development. 
 






A substantial proportion of the plants used in modern herbal preparations 
contain active principles whose effects can be pharmacologically demonstrated 
despite potential complications that could arise from the frequent use of drugs in 
polypharmaceutical combinations (Evans, 1996; Mills and Bone, 1999).  Prescriptions 
under these circumstances are often empirical, resulting from clinical observation and 
practitioner experience rather than rigorous scientific deductions. 
 
Phytomedicines have continuously been used in Kenya in the management of a 
number of diseases and conditions with varied but significant levels of success.  
Examples of such diseases and conditions include malaria, tuberculosis, asthma, 
meningitis, typhoid, tetanus, amoebiasis, oral candidiasis, chronic diarrhoea, herpes 
zooster, helminthiases, skin infections, sickle cell anaemia, insulin-dependent diabetes, 
depressed immune reconstitution, kidney failure, arthritis, fibroids, goitre, gout, prostitis, 
allergy, cholestrolaemia, cervical cancer, sterility and hypertension (Maitai, 1996; 
Aduma, 1998; Orago et al., 2004; Odotte and Orago, 2005). 
 
A number of medicinal plants have multiple uses, being food materials in their 
own right or are food supplements, providing energy, proteins, minerals and vitamins 
needed to maintain proper host cellular function.  These include the appetizer and high 
energy yielding Mondia wytei (Lambert, 2004b) and the proteinous-immune boosting 
combination of Glycin max, Miccuna  quadrilata, Allium sativum and Tragia brevipes 
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(Odotte and Orago, 2005).  Aromatic plants such as Aloe species are used as laxatives 
and for embalming cadavers while Myrrh (Commiphora molmol) together with 
Frankincense are used as perfumes, anti-perspirants, aphrodisiac and in food spicing and 
preservation (Maitai, 1996).  
 
After a review of Volumes 1 and 2 of WHO’s monographs for selected medicinal 
plants, Lambert (2004b) identified ten plant species commonly found in Kenya for which 
there is scientific evidence on the safety, efficacy and quality control for their appropriate 
use (Table 2).  In a number of these cases, clinical data are available to support use 
whereas in others no clinical data have so far been generated and recorded. 
 
Table 2: Selected Kenyan Medicinal plants with a pharmacopoeial 
summary 
 




Allium sativum Present Respiratory, urinary 
disorders 
Aloe vera Present Constipation 
Rauwolfia vomitoria Not available Hypertension 
Zingiber officinale Present Vomiting, diarrhoea 
Syzygium aromaticum Not available Toothache, asthma, 
minor infections 
Eucalyptus globosus Not available Coughs, rheumatism 
Mentha piperita Present Digestive disorders, 
headache 
Ocimum sanctum Not available Diabetes, asthma, 
bronchitis 
Prunus africana Present Prostrate hyperplasia, 
stomach pain 
Azadirachta indica Present Multiple uses 
 
This sustained reliance on traditional medicine among many countries including 
Kenya emanates from increased costs and limited access to allopathic medicine, largely 
due to the underlying problems associated with poverty (Republic of Kenya - KDHS, 
2004). 
  
The potential of medicinal plants and traditional medicine in meeting the primary 
healthcare needs of many Kenyans has not been fully exploited so as to contribute 
significantly to the health care for all paradigm as spelt out through the Alma-Ata 
Declaration of 1978 and the 34th Session of the World Health Assembly in 1981.  This 
has been largely attributed to a number of problems such as overexploitation of medicinal 
plant biodiversity, increased habitat conversion and rapid loss of related indigenous 
knowledge.  Similarly, sporadic and scattered research and development initiatives in this 
area have been rendered ineffective by poor coordination and lack of financial support 
CONSULTANCY REPORT ON SUPPORT TOWARDS  
SUSTAINABILITY OF THE NETWORK PROJECT ON  
MEDICINAL PLANTS AND TRADITIONAL MEDICINE  
(EASTERN AFRICA): KENYA 
Page 10 
 
from the government and international development partners and agencies.  The current 
situation has been exacerbated by gaps and weaknesses in existing policies including 
regulatory and legislative frameworks. 
 
Nonetheless, not all has been lost.  The main aim of WHO/AFRO is to contribute 
to the achievement of health for all in the region by optimising the use of traditional 
medicine (TM) through its institutionalisation, capacity building and integration into 
national healthcare policy including promotion of research and development initiatives 
(Kofi-Tsekpo, 2004; Eriki, 2004).  To this end, a number of landmark initiatives and 
commitments by member states of the Organization of African Unity (now African 
Union) have followed.  These include the declaration in Lusaka, Zambia in 2001 of the 
period between 2001 and 2010 as the Decade for African Traditional Medicine in 
recognition and acknowledgement of the important role TM continues to play in African 
societies in helping achieve the health for all paradigm (OAU/ANG/Dec. 164 XXXVII, 
2001).  This was subsequently followed by the adoption of the Plan of Action (POA) for 
implementation of the Decade for African TM by Heads of State and Governments in 
Maputo in 2003 and the Institution of the African Traditional Medicine Day by the WHO 
Director General to be observed every August 31 yearly (Eriki, 2004).  The Ministry of 
Health in Kenya through the Department of Standards and Regulatory Services should 
register TMPs and integrate their practice in national health care system in recognition of 
the role they play in primary health care  provision where upto 70% of the population 
consult them. 
 
(b) Commercialization and Conservation-related issues 
 
The global demand for raw herbal products and medicines is on the upward trend.  
The WHO estimates of sales were in excess of US dollars 65 billion with Africa 
probably contributing US dollars 6 billion of this total from the volume of plant 
materials in excess of 1 million metric tonnes collected annually in Africa 
(Lambert, 2004a; Rogo, 2004).  It was estimated that upto 40% of all 
pharmaceuticals in industrialized countries are derived from natural sources, 
mainly plant biodiversity (WHO, 1996a) which include thousands of powerful, 
efficacious drugs that save lives somewhere in the world almost every second of 
the day (Huxtable, 1992). 
 
Although a lot of people in Eastern Africa derive income from medicinal plant 
collection and/or trade, limited information is available on economic value of 
these at the local, regional and international markets.  In Kenya, many medicinal 
and aromatic plants are exported to Europe and USA presumably through the 
“black market”, notably Prunus africana, Warbugia ugandensis, Azadirachta 
indica and Aloe species. 
 
The traditional medicine sector in Kenya represents an important natural resource-
base for economic development by virtue of providing a means of livelihood for 
many people including herbal plant collectors, transporters, vendors, traditional 
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medicine practitioners, users, consumers and entrepreneurs.  Employment 
opportunities would be increased and income generation to support all 
beneficiaries enhanced if utilization of this natural resource-base was maximized 
while protecting the environment from degradation (Michieka, 2004).  However, 
medicinal plant biodiversity and traditional health services in Kenya are currently 
under increasing threat mainly due to a high rate of human population growth, 
underlying poverty, expanding agriculture, deforestation, grazing, fires and 
unsustainable harvesting from wild stocks and trade (Lambert, 2004a; Michieka 
2004).  This escalating loss of biodiversity in terms of species and ecosystem 
depletion could have an irreversible impact unless appropriate action is taken to 
regulate trade and traditional medicine practices to ensure future sustainability 
through medicinal plant conservation and cultivation (WWF, 1993; Marshal, 
1998). 
 
The Ministry of Agriculture should promote farming in medicinal plants in 
collaboration with farmers, researchers and traditional medicine practitioner 
associations to identify conservation, propagation and harvesting practices to 
ensure availability of products of medicinal plants for rational commercilaization.  
The Ministry of Trade and Industry should document the volume and value of 
trade in medicinal plants and identify markets. 
 
c)  Policy, Administrative and Legal framework issues 
For more than a decade, a policy making process has been going on at global, 
regional and national levels to address the needs, problems and challenges facing 
the rational use of biological resources to achieve sustainable development and 
conservation objectives, particularly in developing countries. As regards 
medicinal plants and traditional medicine, the Chiang Mai declaration and 
subsequently the WHO/IUCN/WWF Guidelines on the Conservation and use of 
medicinal plants (1993) laid the groundwork, calling on governments to develop 
national strategies on the conservation and use of medicinal plants. The 
Convention on Biological Diversity (CBD, 1992) provides a global and broad 
policy framework and a legal instrument whose objectives are to conserve 
biodiversity, use it sustainably, and ensure fair and equitable sharing of benefits. 
To this end the CBD recognizes the importance of traditional knowledge, 
innovation and practices of indigenous and local communities that are relevant for 
the conservation and use of biological diversity (CBD, 2001); calls on Parties to 
identify components of biodiversity important for conservation and sustainable 
use and monitor them (medicinal plants are highlighted among priority species); 
and sets an agenda, through the Global Strategy for plant conservation ( April, 
2002), to halt the rate of loss of plant species with 16 specific targets most of 
which are relevant to medicinal plants. 
 
Issues of access and benefit sharing pertaining to biological genetic resources 
have been debated at international level within the framework of the CBD. The 
6th session of the Conference of the Parties adopted the Bonn Guidelines on 
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Access to Genetic Resources and Fair and Equitable Sharing of the Benefits 
Arising out of their Utilization (COP 6, Decision VI/24, as ''a useful first step of 
an evolutionary process in the implementation of relevant provisions of the 
Convention related to access to genetic resources and benefit sharing''. They are 
intended ''to serve as inputs (for countries) when developing and drafting 
legislative, administrative or policy measures on access and benefit sharing''. 
Besides, intellectual property rights issues also arise in this context. 
 
The convention on International Trade in Endangered Species of Fauna and Flora 
(CITES) provides a legal framework for the regulation of trade in those 
endangered plant and animal species that are exploited commercially. 
 
As regards healthcare, the WHO over the years adopted a number of resolutions 
and recommendations drawing attention to the important role played by 
traditional medicine and medicinal plants in ensuring primary healthcare of the 
majority of the world population, especially in developing countries. Through its 
traditional medicine programme, WHO developed various guidelines, standards 
and policies related to herbal therapies, practice, ethics, safety and efficacy, 
methodologies for research, legal status, and integration traditional medicine into 
national health care systems (Eriki, 2004). 
 
At the African level, the OAU/AU adopted the ''African Model Law for the 
Protection of Rights of Local Communities, Farmers and Breeders for the 
Regulation of access to biological diversity and to community knowledge and 
technologies as the duty of the State and its people. It requires the prior informed 
consent of both the State and the local communities before granting access to 
biological resources, and recognizes benefit sharing as a right of local 
communities consistent with the basic tenets of the CBD (Ekpere, 2002). 
 
At national level, a number of countries in Eastern and Southern Africa 
developed policy directives and strategies on conservation of biological resources. 
Kenya and Uganda developed National Biodiversity Strategies and action plans 
that stress the need for promoting the conservation of biodiversity and Action 
Plans that stress the need for promoting the conservation of biodiversity and 
sustainable utilization of its components, and set up National Environment 
Management Authorities (NEMAs). In Ethiopia, the mandate of the institute of 
Biodiversity Conservation and Research (established in 1998) is primarily to 
conserve, evaluate and enhance the sustainable utilization of genetic resources 
(plants, animals and microbes) as reported by Hunduma, (2002). Several countries 
in the region have also national environmental and forest policies.  
 
 
There are also elements of policy and legislation pertaining to traditional 
medicine in many countries (Tanzania, Lesotho, Zambia, Zimbabwe, Namibia).  
Ethiopia, Mozambique, Madagascar) in the Eastern and Southern African Region 
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However, these policies are not coherent or comprehensive in many cases. 
There are gaps within existing policy and legal frameworks such as lack of 
harmonization, duplication of legislation, and outdated laws (e.g. Witchcraft Acts 
relating to traditional medicine). Besides, their implementation is constrained by a 
number of factors including lack of/inadequate public awareness, insufficient 
capacity for research and limited infrastructure and resources. Domestication of 
international conventions and treaties and regional model policies and laws 
remains problematic. 
 
In the Kenyan context, some of the new policy, administrative and legal 
frameworks that urgently require formulation to mainstream TM practice in the 
national healthcare system include: 
 
• A clear and comprehensive policy on TM strategy and sustainable 
development. 
• A legal framework for TM through the enactment of The Traditional and 
Alternative Healthcare Practitioners Bill, 2003 (ROK, 2003b). 
• An independent, administrative and institutionalised  TM framework 
creating an enabling environment for interactive healthcare delivery 
system, such as the establishment of the National Research Centre for 
Medicinal Plants and Traditional Medicine (NRC-MPTM). 
• An action plan to implement TM policy using the available WHO 
Guidelines (WHO, 1996b, 1998a, 1998b). 
• Policy considerations in the ministries of Health, Environment and Natural 
resources, Agriculture, Tourism and Wildlife, Livestock and Fisheries, and 
Trade and Industry with regard to the natural sources of traditional 
medicine and their sustainable utilization and development. 
 
Similarly, certain existing policy, administrative and legal frameworks require 
updating and/or strengthening to acknowledge and refocus the contribution of 
traditional medicine in the national primary healthcare provision.  These include: 
 
• The Kenya National Drug Policy (ROK, 1994). 
• The National Health Sector Strategin Plan: 1999-2004 (ROK, 1999). 
• The Pharmacy and Poison Act, Chapter 244 (ROK, 2002). 
• The Dangerous Drugs Act, Chapter 245. 
• The registration of Non-Indigenous Traditional Medicine Practitioners by 
the Department of Standards and Regulatory Services in the Ministry of 
Health (ROK, 2003a). 
• The Kenya Pharmaceutical sub-Sector Review for proposed Bank support 
for Health Sector-wide Approach (World Bank, 2003a). 
• The Kenya Pharmaceutical Sector Review: An Analytical Work Concept 
Note (World Bank 2003b). 
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d) Research and Development Issues 
 
Over the last three decades, most of research activities is sub Saharan Africa have 
concentrated on ethnobotanical and taxonomic surveys.  Other studies focused on 
phytochemical and pharmacological screening of plants in an effort to discover 
and characterize active ingredients. A few investigations were successful in 
validating the safety and efficacy of traditional remedies and led to the 
development of phytomedicines in some countries (Ghana, Mali, Madagascar, 
Nigeria, Rwanda). Some of these activities were/are undertaken within networks 
such as the Natural products Research in East and Central Africa (NAPRECA). 
Recent activities supported by the IDRC in East Africa (Kenya, Uganda) have 
mainly focused on the documentation of traditional/local knowledge of medicinal 
plants and their use for primary health care, and are targeting most used and 
reportedly endangered plants with a view to improving their availability and 
sustainable management by local communities. A few activities are addressing 
safety issues of some traditional therapies. Various institutions in Ethiopia 
coordinated by the Institute of Biodiversity Conservation and Research currently 
carry out other research activities. In general, however, very few research 
activities have been carried out to address the conservation and sustainable use of 
medicinal plant genetic resources (geographic distribution, ecological 
requirements, reproductive biology, seed storage and germination, sustainable 
management). Besides, research results are scattered and their impact on both 
health and economic objectives has been very limited. This is due, in part, to the 
diversity of researchers' interests, approaches and methodologies, and lack of 
appropriate policies. 
 
More research is still needed on various issues relating to health and 
nutrition, conservation and sustainable use/management, and policy notably, in 
order to achieve greater impacts on health, social, economic and conservation 
goals. From the health care stand point, the overall goal of research should be to 
reinforce the development of improved traditional practices and herbal medicinal 
products in order to facilitate the integration of traditional medicine into national 
healthcare delivery services. To this end, further research should build on past and 
current research results and identify the most promising opportunities and issues 
to focus on.  
Some of the research questions that need to be addressed in this regard are: 
 
• How can scientific knowledge be used to strengthen local practices 
of traditional medicine in East Africa and Kenya in particular? 
• What are the key considerations in integrating traditional medicine 
and use of medicinal plants in public health care sector in Kenya?  
• What are the factors and policies that determine and constrain 
household dietary diversity and nutritional status; and what are the 
opportunities to enhance it? 
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Particular attention should also be paid to sensitization on WHO guidelines and 
their appropriate domestication, establishment of structures and mechanisms for 
implementation, and strengthening dialogue between all stakeholders. 
 
As regards conservation and sustainable management, the overall role of research 
should be to contribute to halting the loss of biodiversity and to improved 
livelihoods of the people, through sustainable utilization of medicinal plants. 
Projects should be designed to complement past and current conservation studies 
with a focus on the most used plants in traditional medicine in Kenya, as well as 
those which are traded and reportedly of conservation concern. Some of the 
research questions that need to be addressed in this regard are: 
 
• How can integration of cultivation and wild harvesting lead to 
sustainable management of medicinal plants and their habitat? 
• What are the best tools and practices for quality management and 
standardization that promote sustainable use of medicinal plants in 
Kenya.  
• What are appropriate mechanisms, including suitable tenure 
arrangements, to ensure sustainable management of medicinal 
plants and their habitat in Kenya, while improving equity in access 
to and benefits from medicinal plant resources?   
 
Efforts of many governments in Africa in general and Kenya in particular are 
currently directed towards poverty reduction and food security as major goals of 
their national programmes. Medicinal plants can contribute towards these goals. 
For example the President of Uganda has recently urged the National 
Chemotherapeutics Research Laboratory  (NCRL) to play a leading role in 
industrial preparation of herbal medicines, and promote cultivation of medicinal 
plants that can be exported. In this area, research is needed to support community-
based processing of plant materials, quality control and quality management, and 
to provide relevant market information to producers/harvesters to increase their 
bargaining power and market share. Where possible, the use of certification 
schemes may be applied to ensure market security whilst enhancing quality 
control. Some of the research questions to be addressed are: 
 
• What are the social, biological and legal impacts of domestication and 
cultivation of medicinal plants? 
• What institutional mechanisms can support more equitable benefit 
sharing among local producers (e.g. markets, access to information, 
bio-partnerships, etc.) in Kenya? 
• What are the best mechanisms to resolve potential conflicts between 
local level access and benefit sharing priorities, and 
national/international interests? 
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As regards policy and legal frameworks, there is a clear need for assessment of 
existing policies and legislation relating to environment, forests, wildlife, plant 
genetic resources (access, ownership, protection of community rights, 
conservation), health and traditional medicine, intellectual property rights, etc, in 
order to identify gaps to be addressed  in relation to medicinal plant issues. 
Research also needs to look into the challenges faced with the policy 
implementation process in Kenya. The aim is to advice the country on matters 
relating to policy development and implementation, with a view to facilitating 
access to plant resources/genetic material while at the same time ensuring 
protection of communities’ rights and equitable benefit sharing, promoting 
sustainable development through conservation and sustainable use of medicinal 
plants, integrating traditional medicine into public health services, harmonization 
of sub-regional (Eastern Africa) policies and legislation and domesticating 
international conventions and treaties and regional (Africa) model policies and 
laws. Notably a review of process in domesticating and implementing the WHO 
guidelines, CBD decisions and policies such as the Bonn Guidelines on Access 
and Benefit sharing and the AU declaration along with the adoption of the criteria 
presented by the African Model Law would be worthwhile. In this regard, 
research needs to identify key issues of concern and develop policy briefs, work 
with communities to develop model scenarios and case studies, to facilitate policy 
forums and dissemination workshops and establish strategic links with local, 
national, regional and international relevant organizations (Traditional Medicine 
Practitioner Associations, CBOs, FBOs, NGOs, East African COMMUNITY, 
COMESA, SADC, AU, NEPAD, CBD, NIH, National Institute of Medical 
Herbalists- NIMH: UK, British Herbal Medicine Association –BHMA, European 
Scientific Cooperative on Phytotherapy –ESCOP, Oxford International 
Biomedical Centre –OIBC, WIPO). 
 
The inherent problems in the Kenya research and development agenda on 
medicinal plants and traditional medicine emanate largely from gaps in: 
 
• Regulatory control or policy to coordinate and harmonize research and 
information sharing on medicinal plants and their sustainable 
utilization in traditional medicine. 
• Capacity building for traditional medicine practitioners and 
researchers to improve their practice and skills, and strengthens their 
weak TMP associations to prevent incompetent TMPs (quacks) from 
practising. 
• Mutual understanding and trust between TMPs and their conventional 
counterparts by incorporating aspects of TM in the conventional 
training curricula of health professionals and vice versa to strengthen 
collaboration and cross-referrals. 
• Standardized and research-based evidence on safety, efficacy and 
quality of TMs arising from lack of clear recognition by the 
government and validation by scientists of the role of TMPs and value 
CONSULTANCY REPORT ON SUPPORT TOWARDS  
SUSTAINABILITY OF THE NETWORK PROJECT ON  
MEDICINAL PLANTS AND TRADITIONAL MEDICINE  
(EASTERN AFRICA): KENYA 
Page 17 
 
to the healthcare system. 
• Documentation and inventory on volumes and value of available 
natural sources of traditional medicine in Kenya developed by the 
Ministries of Environment and Natural Resources, Tourism and 
Wildlife in collaboration with TMP associations, researchers and local 
communities. 
• The Ministry of Agriculture of a policy that promotes farming in 
medicinal plants as new cash crops in consultation with TMP 
associations and farmers to identify conservation, propagation and 
harvesting practices that ensure sustainability of this sector in 
commercialisation for enhanced income generation. 
• An enabling political, economic, budgetary allocations, infrastructural 
provisions and regulatory environments for supporting and up-scaling 
good manufacturing practices to spur local production of TMs. 
• An established legal framework for the protection of Intellectual 
Property Rights, Access and Benefit sharing to enhance free flow of 
information among Key stakeholders as a strategy in the preservation 
of indigenous knowledge in TM as a national system for adverse 
reactions to traditional medicines. 
• Setting up a monitoring system for adverse reactions to traditional 
medicines. 
• Regional and international collaboration. 
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3.2  Rationale for a National Network Project 
 
There are currently a number of stakeholder organizations such as CBOs, 
NGOs, traditional medicine practitioner associations, research institutions and 
universities working on various aspects medicinal plants and traditional medicine 
in Kenya. Some sub-regional networks with operational branches in Kenya and a 
few Kenyan-based networks also exist. These include PROMETRA, NAPRECA, 
ASARECA, THETA, SABONET, African Ethnobotany Network, VicRes, 
AICAD, and National Council for Associations for Alternative Complementary 
Medicine and Research, KWG-MAPS, NCPD – Intersectoral Network on 
traditional medicine and the CCMB – Kenyatta University. 
 
Despite the fact that these stakeholder institutions and networks may be 
addressing common and similar problems and issues, no formal national forum 
for strategic collaboration and information sharing has been established. 
Furthermore, certain concerns have emerged regarding various approaches, 
research designs and methodologies used by various networks in their 
investigations meant to find solutions to existing problems. This has impacted 
negatively on the national priority setting in the area of natural resource 
conservation and rational utilization of medicinal plant biodiversity in traditional 
medicine practice to spur economic development and ensure sustained livelihoods 
as a poverty reduction strategy in line with the Millennium Development Goals 
(WHO, 2003a). Consequently we have continued to witness blatant duplication of 
efforts, poor coordinating of information sharing, scattered research-derived 
results and lack of harmonized investigative procedures to enhance the quality 
and reproducibility of these findings in various laboratories and/or clinical 
settings. There is therefore, an urgent need for a national platform to bring 
together all relevant stakeholders to dialogue, work together and find solutions to 
general issues and challenges on thematic areas of medicinal plant biodiversity 
and traditional medicine. 
 
A national network with such a stature and a determined structure will fill 
this gap by creating a platform and an enabling environment with unsurpassed 
opportunities for stakeholders to share freely pertinent information and 
consolidate data on their respective activities, harmonize their approaches, 
research designs and methodologies, work together and develop collaborative 
projects to address common challenges and priority issues relating to the use and 
conservation of medicinal plants. This forum will also enable stakeholders attain 
critical masses and competencies for strategic research projects in many areas 
(capacity building, clinical trials, conservation studies, policy formulation, IPRs 
issues, infrastructure development, technology transfer) and initiate processes to 
instil trust and bridge gaps between researchers, communities, traditional 
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medicine practitioners, policy/decision makers, consumers, development partners 
and private entrepreneurs. 
 
The urgent need for institutionalized TM (CAM) practitioners and practices was 
underscored during the inter-sectoral workshop on Traditional Medicine, 
HIV/AIDS, Research and sustainable development in Kenya in June, 2004 
(NCPD Report, 2004). It was observed that since CAM practices and the 
practitioners were diverse, less exclusive, less organized, often maligned and 
struggle for recognition and respectability, it was instructive to give it a structure 
where safety, quality and efficacy of treatments and procedures could be 
monitored and evaluated (Crellin and Ania, 2002; Orago, 2004). Earlier on, the 
British Medical Association (1993) had contended that CAM systems needed to 
be institutionalized to establish and sustain good practice features which included 
having an organized structure, a single register of members, guidelines on 
relationships with conventional medical practitioners, a sound training at 
accredited institutions, an effective code of Ethics, agreed levels of competence 
and a proven commitment to research. 
 
To instil in CAM systems attributes of good practice in Kenya, Orago (2004) 
recognized the essence of bringing together inter-sectoral stakeholders in an 
independent institution with an enabling environment to foster the development of 
strategic partnerships on CAM research and integration into the national 
healthcare policy. 
 
The envisaged independently institutionalized National Network project on 
medicinal plants and traditional medicine will constitute the requisite strategic 
foundation on which this resource will be harnessed and expanded sustainably for 
the common good of all the stakeholders. 
 
3.3 The structure and scope of the National Network Project 
 
3.3.1 The proposed title of the project 
 
The title of the project shall be: 





Contribute to the improved livelihoods of healthy, wealthy and technologically 
empowered Kenyans through effective strategic stakeholder partnerships and 
sustainable utilization of medicinal plant biodiversity and their products used in 
the integrated traditional-conventional healthcare system. 
 
3.3.3 Mission 
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To improve health and create wealth through coordinated research, training, 
medicinal biodiversity conservation, rational and sustainable utilization, 
commercialization, regulation, integration, protection and preservation of 
traditional medicine practice as a natural culture heritage. 
 
3.3.4 Specific Objectives 
 
• Assess current research activities, policy and legal frameworks on 
medicinal plants and traditional medicine in Kenya, in order to identify 
gaps and determine national research priorities. 
• Enhance research capacity and harmonization of research designs and 
methodologies for sustainable management of medicinal plants and their 
uses in traditional medicine. 
• Promote the development of collaborative projects on herbal and other 
traditional remedies, conservation of medicinal plants and sustainable 
livelihoods in Kenya. 
• Strengthen the capacity of traditional medicine practitioner associations 
and the collaboration between them and health workers, researchers, 
consumers and policy/decision makers in order to support integration of 
traditional medicine in the national public health care. 
• Contribute to the development and implementation of appropriate policies 
and legal frameworks pertaining to medicinal biodiversity conservation 
and traditional medicine including access to and benefit sharing at 
national, regional and international levels. 
• Develop partnerships with mass and electronic media, the government of 
Kenya, regional and international organizations for dissemination and 
scaling up of research findings on medicinal plants and phytomedicines. 
• Strengthen community-based biodiversity conservation and rational 
exploitation initiatives to function as income generating ventures. 
• Establish standardized systems for monitoring and scientific evaluation of 
treatments and procedures in traditional medicine practice for safety, 
quality and efficacy. 
 
3.3.5 The Management structure of the NRC-MPTM 
 
The NRC-MPTM shall be established as a legal independent National Institution 
with an administrative structure and a mandate.  It shall function as a 
multisectoral coordinating unit for all stakeholders activities linking traditional 
medicine practice with medicinal plant research and sustainable development.  It 
could initially be housed or attached to an existing national research institution, a 
relevant Government Department or a public University.  
 
The terms of reference and mandate for the NRC-MPTM shass be as follows: 
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• To bring together the national stakeholders under the respective 
themes of health, conservations, livelihoods and policy and provide a 
network secretariat. 
• To facilitate national assessments of capacity, capability, resources and 
identify gaps, strengths, weaknesses, opportunities and threats. 
• To facilitate the implementation of selected activities prioritised at 
national and regional level. 
• To harmonize and publicize the outputs of the network at national 
level. 
• To promote education and public awareness on medicinal plants and 
traditional medicine issues through appropriate channels such as 
media, NGOs, CBOs, FBOs. 
• To develop partnerships/relationships with relevant government 
institutions, relevant regional and international organizations as well as 
interested development partners. 
• To stimulate and enhance  the effective consideration of social and 
gender balance within the network to provide a planform for  
sustainable development at grassroots level. 
 
An IDRC officer will coordinate the work of NRC-MPTM in collaboration to 
develop necessary methodological tools, terms of reference for studies to be 
undertaken and agenda of the workshops to be organized.  The officer will ensure 
the overall monitoring of the network project. 
 
The management or administrative structure of NRC-MPTM shall comprise of a: 
 
• Management Board (MB)/Steering Committee (SC) 
• Secretariat 
• Technical Advisory Committee (TAC) 
 
a) The MB will be composed of 10 members or a 30% membership drawn from the 
heads (or their designated representatives) of participating key stakeholder 
institution in Kenya including representatives of development partners and 
international NGOs.  The  membership of MB will rotate on an annual basis 
among heads of key stakeholder institutions.  The MB will have a Chairman and a 
Vice Chairman elected annually from among the members.  The Chairman or 
Vice Chairman in his/her absence will set the agenda of the MB meeting and chair 
all meetings.  The MB will: 
 
• Be responsible for the overall management of the network, for setting up 
the policy and priority activities of the network. 
• Facilitate and oversee the project implementation processes. 
• Provide institutional ownership as well as linkages and regional 
integration. 
• Ensure follow up at national and regional levels of the Network outcomes 
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such as policy briefs. 
• Approve a Memorandum of Understanding (MOU) between collaborating 
institutions to be used for implementation of collaborative research 
projects. 
• Approve Budget Estimates and Expenditure Accounts of the Network 
project. 
• Play a leading role in developing the Network’s programmes and 
fundraising. 
 
b) The Secretariat will be composed of the Director of NRC-MPTM who will also 
be Secretary to the MB and head of the Kenyan component of the Regional 
Network project.  The Director will have three Deputy Directors, each in charge 
of Health, Conservation and Trade.  The Director and the 3 Deputy Directors will 
be recruited competitively and will serve a renewable contract of 3 years. 
 
c) The TAC will be composed of the Director and the 3 Deputy Directors of NRC-
MPTM and other representative specialists drawn from participating key 
stakeholder institutions.  The TAC will: 
 
• Be responsible for the hands-on project implementation. 
• Provide technical overview and outcomes of the project’s implementation. 
• Prepare updates on the ongoing projects for the MB. 
• Prepare terms of reference for specific studies to be undertaken. 
• Review collaborative research proposals. 
• Vet what should be published. 
• Prepare MOUs between collaborating institutions that ensure respect for 








4.0 AN OUTLINE OF GAPS IN THE CURRENT PROJECT 
AND RECOMMENDATIONS OF PRIORITY FUTURE 
FOCAL AREAS FOR NETWORK ACTIVITIES 
 
For the current project to meet all its objectives satisfactorily, certain gaps need to 
be identified and efforts made to address them.  These gaps have been identified 
and recommendations of priority future focal areas for network activities 
summarized in Table 3. 
 
Table 3:  Gaps in the current project and recommendations of priority  
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      future focal areas for network activities 
 
  
Gaps in current project Recommendations of priority areas for network 
activities 
(a) Policy formulation,  
     implementation and    






































(i) Develop a clear and comprehensive  national  
    policy on TM practice and  sustainable  
    development that: 
 
• Links traditional medicine practice with 
medicinal plant research and development 
within one multsectoral coordinating body. 
• Regulates and promotes the production, 
harvesting, processing and marketing of 
medicinal plants and traditional medicines. 
• Incorporates the conservation, cultivation, 
propagation, commercialization and marketing 
of medicinal plants into national economic and 
agricultural development plans. 
• Supports the manufacture of quality traditional 
medicines for local consumption and export to 
maximize the potential economic benefits. 
• Recognizes traditional medicine practice and 
its practitioners as legitimate  professionals. 
• Removes all the restrictive legal impediments 
to the practice of traditional medicine and 
access to medicinal plants. 
• Promotes strategic partnerships and 
collaboration with other national and 
international organizations and countries. 
 
(ii) Develop national action plans to   
     implement the policy on medicinal  
     plants and traditional medicine     
     using the available WHO Guidelines  
     (WHO, 1996b, 1998a, 1998b, 2000,  
      2002). 
(iii) Develop a legal framework for TM  
      through the enactment of the  
      Traditional and Alternative  
      Healthcare Practitioners Bill, 2003  
     (ROK, 2003b) that: 
 
• Defines TM practices, tools and products and 
its role in the provision of healthcare. 
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(b) Multisectoral  
     Coordination 
• Enhances self regulation and institutionalizes 
TMP and TM knowledge as a natural cultural 
heritage. 
• Promotes certified registration and licensing of 
qualified and competent members.  
• Sets national standards for the scientific 
evaluation of TM and TM therapies. 
• Establishes and enforces a code of ethical TM 
practice. 
• Harmonizes relevant existing weak and 
outdated legislative frameworks. 
• Determines and spells out the required 
provision of resources for the development of 
TM. 
• Establishes systems for monitoring of safety, 
efficacy and quality of TM. 
• Establishes cultivation and conservation of 
medicinal plants to ensure sustainable use of 
this resource. 
• Promotes communication, collaboration and 
interaction between TMPs and allopathic 
medicine practitioners and possible integration 
in the delivery of healthcare services. 
• Provides opportunities for continuing 
education and training. 









(i)  Establish a legally constituted  
     independent, multisectoral  national  
     institution with an administrative  
     structure and mandate (such as NRC- 
     MPTM) to: 
 
• Coordinate all stakeholder activities linking 
traditional medicine practice with medicinal 
plants research and sustainable development. 
• Includes all relevant stakeholders and 
government ministries of health, agriculture, 
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environment and natural resources, education, 
trade and industry, tourism and wildlife, 
planning and national development.  
• Serves as a national management or 
coordinating body. 
• Provides an institutional base for TM practice 
and TM practitioners. 
• Creates awareness on TM and medicinal plant 
issues. 
 
(ii) Develop and implement through accredited   
     training institutions harmonized capacity  
     building programmes for various competency  
     levels of TMPs, farmers, TM researchers and  
     entrepreneurs by: 
 
• Selectively running foundation courses in 
human biology, hygiene and sanitation; 
biology of pathogens, aetiology, clinical 
presentation, diagnosis, epidemiology and 
treatment; plant biology, growth, development 
taxonomy, biodiversity conservation, 
cultivation, harvesting and sustainable 
utilization; drug chemistry and interactions in 
biological systems; good manufacturing 
practice, safety, efficacy, quality, processing, 
packaging and marketing; communication 
skills and ethics in professional practice; 
research methods, data collection, management 
and interpretation; ICT in medical practice; 
Report writing. 
• Conducting special courses to infuse basic 
scientific principles, procedures and 
applications into TM practice. 
• Strengthening TMP associations to function in 
an integrated healthcare system. 
• Strengthening post-training collaboration and 
cross-referrals through an intercurriculum-
designed trust  building between TMPs and 
allopathic medical practitioners.  
 
 
  
 
 
